AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Vysis Inc of Downers Grove, IL has given Abbott Laboratories of Abbott Park, IL, distribution rights to its 2 genomic tests for breast and bladder cancer.
Abbott will be the exclusive distributor in North America and Europe of the DNA-based tests PathVysion HER-2 assay and the UroVysion assay.
PathVysion HER-2 assay detects and quantify the HER-2 gene in breast cancer patients, while UroVysion assay is for the detection of genetic changes in the urine's bladder cancer cells.
Both tests …